Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, centilene, and centsteel; and other medical devices that comprise centipunch, centcel, centiitape, centiiwax, centilene mesh, centipace, and centipled, as well as disposable surgical skin stapler. Centenial Surgical Suture Ltd. was incorporated in 1995 and is based in Thane, India.
| Current Price | ₹86.30 |
|---|---|
| Market Cap | ₹31 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Medical Consumables |
| P/E Ratio | -14.3 |
| Return on Equity | -7.43% |
| 52-Week Range | ₹76.27 – ₹189.00 |
| Beta (1Y) | 1.02 |
Centenial Surgical Suture Ltd. is trading at ₹86.30, with a market capitalisation of ₹31 Cr.
Centenial Surgical Suture Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).
Centenial Surgical Suture Ltd. has a P/E of -14.3 and a return on equity of -7.43%.